Remove Life Science Remove Research Remove Sales
article thumbnail

Viatris to acquire Oyster Point and Famy Life Sciences

Pharmaceutical Technology

Viatris has signed definitive agreements to acquire Oyster Point Pharma and Famy Life Sciences in a deal totalling nearly $700m-$750m in cash to establish an ophthalmology franchise. Famy Life Sciences has an ophthalmology portfolio that complements Viatris. Viatris plans to finance these purchases in cash.

article thumbnail

GSK and Wave Life Sciences partner to develop oligonucleotide therapeutics

Pharmaceutical Technology

GSK has entered a strategic partnership with Wave Life Sciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. The discovery alliance, with a preliminary research period of four years, will aid GSK in progressing up to eight programmes and Wave to develop up to three programmes.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Life Science Consulting Jobs: A Unique Career

XTalks

Life science consulting can be a rewarding career and the job outlook is promising for the future. . Perhaps you have heard of life science consulting jobs but do not exactly know what type of work is involved, or the education and experience needed to become a life science consultant. Job Description.

article thumbnail

The mysterious UK Life Sciences Council

pharmaphorum

Life Sciences Council. Do you know about the Life Sciences Council (LSC)? The LSC has a website on Gov.uk, but the page says Life Sciences Council. A post from the director of health and life sciences at Innovate UK, Richard J Hebdon, also bigged up the news before the Council met about four health missions.

article thumbnail

COVID drives a customer experience shift in life sciences CRM

pharmaphorum

The future of life sciences CRM will be defined by rapid digital transformation and a focus on customer experience – and those who stick to old ways of working will be left in the dust, according to new research from Gartner. One of these companies is Omnipresence. I don’t think it’s possible to go back from this.

article thumbnail

Agents for change: the women breaking through in life sciences venture capital

pharmaphorum

But things are changing and women are becoming more influential in life sciences VCs, with an increase in business going to all-female teams. The story was slightly different in life sciences, however: all-female teams in biotech and pharma received 10% of funding compared with 7% for all-male”.

article thumbnail

Life sciences must become cloud-first to seize the science of tomorrow

pharmaphorum

If the power of the life sciences industry to innovate and collaborate were ever in doubt, the speed at which vaccines for COVID-19 were discovered, developed, trialled, approved and manufactured have confirmed just how dynamic the industry can be. And those volumes will only increase. From face-to-face to FaceTime.